The Docking and Dynamics Simulation of Natural Compounds from Abrus precatorius L. for Investigating the Possibility of GluR3 Inhibition to Treat Depression DOI
Rachid Rezgui, Talal Alharazi, Khalid Alshaghdali

et al.

Pharmacognosy Magazine, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 2, 2024

Background The rising incidence of Major Depressive Disorder (MDD), in conjunction with the inadequate effectiveness and resistance observed existing therapeutic approaches, emphasizes urgent need to investigate novel therapeutics that provide enhanced efficacy reduced adverse effects. Abrus precatorius L., an herb is readily available frequently utilized traditional medicine, prescribed patients suffering from neurological disorders. Purpose goal this study discover active compounds A. plant can specifically target GluR3 receptor using silico techniques, develop a safe efficient treatment for MDD. Methods Homology modeling, molecular docking, dynamics simulation, absorption, distribution, metabolism, excretion, toxicity (ADMET) analysis were employed investigation screen derived precatorius. Their potential inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid activity, glutamate 3 (GluR3), which associated MDD, was objective study. Results Among 31 precatorius, 15 successfully cleared ADMET filter criteria. Subsequently, best homology model constructed Phyre2. This facilitated into intramolecular interactions exhibited by filtered compounds. Notably, four most pronounced binding affinities are identified their PubChem compound IDs (CIDs): 160511, 44257585, 1983, 145857. affinity internal top-ranking compound, CID subjected further validation through MD simulations, affirming its sustained stability binding. Conclusion CIDs: 160511 no notable side effects high stability, making it drug candidate To ascertain precise medications, additional vitro, vivo, clinical studies required.

Language: Английский

Facile green synthesis of silver nanoparticles derived from the medicinal plant Clerodendrum serratum and its biological activity against Mycobacterium species DOI Creative Commons

Vidyasagar,

Ritu Raj Patel,

Sudhir Singh

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(10), P. e31116 - e31116

Published: May 1, 2024

Language: Английский

Citations

8

The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles DOI Creative Commons
Helena I. Boshoff, Neha Malhotra, Clifton E. Barry

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(2), P. 211 - 211

Published: Feb. 6, 2024

Tuberculosis (TB) is notorious as the leading cause of death worldwide due to a single infectious entity and its causative agent, Mycobacterium tuberculosis (Mtb), has been able evolve resistance all existing drugs in treatment arsenal complicating disease management programs. In drug discovery efforts, natural products are important starting points generating novel scaffolds that have evolved specifically bind vulnerable targets not only pathogens such Mtb, but also mammalian associated with human diseases. Structural diversity one most attractive features products. This review provides summary fused-nitrogen-containing heterocycles found reported literature known antitubercular activities. The structurally targeted discussed this could provide revealing insight into chemical aspects biological functions for TB efforts.

Language: Английский

Citations

6

Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti-Mycobacterium tuberculosis agents targeting enoyl acyl carrier protein reductase (InhA) DOI Creative Commons
Rasha Z. Batran, Ahmed Sabt, Jarosław Dziadek

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(30), P. 21763 - 21777

Published: Jan. 1, 2024

In this study, we designed and synthesized a series of coumarin derivatives as antitubercular agents targeting the enoyl acyl carrier protein reductase (InhA) enzyme. Among compounds, tetrazole derivative 4c showed most potent effect with minimum inhibitory concentration value (MIC) 15 μg mL-1 against Mtb H37Rv could also inhibit growth mutant strain (ΔkatG). Compound was able to penetrate Mtb-infected human macrophages suppress intracellular tubercle bacilli. Moreover, target InhA enzyme an IC50 0.565 μM, which superior reference inhibitor triclosan. Molecular docking compound within active site revealed importance 4-phenylcoumarin ring system moiety for activity. Finally, physicochemical properties pharmacokinetic parameters were investigated.

Language: Английский

Citations

6

Synthesis and characterization of PANI and PANI-indole copolymer and study of their antimalarial and antituberculosis activity DOI Open Access

Purnima Chaubisa,

Dharmendra Dharmendra,

Yogeshwari Vyas

et al.

Polymer Bulletin, Journal Year: 2023, Volume and Issue: 81(4), P. 3333 - 3353

Published: June 6, 2023

Language: Английский

Citations

16

Indole-Containing Metal Complexes and Their Medicinal Applications DOI Creative Commons
Zahra Kazemi, Hadi Amiri Rudbari, Nakisa Moini

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(2), P. 484 - 484

Published: Jan. 18, 2024

Indole is an important element of many natural and synthetic molecules with significant biological activity. Nonetheless, the co-presence transitional metals in organic scaffold may represent factor development effective medicinal agents. This review covers some latest most relevant achievements pharmacological activity indole-containing metal complexes area drug discovery.

Language: Английский

Citations

5

Coordination of azol(in)ium dithiocarboxylate ligands to Au(iii): unexpected formation of a novel family of cyclometallated Au(iii) complexes, DFT calculations and catalytic studies DOI Creative Commons
Paula Pérez‐Ramos,

María A. Mateo,

David Elorriaga

et al.

Dalton Transactions, Journal Year: 2024, Volume and Issue: 53(22), P. 9433 - 9440

Published: Jan. 1, 2024

We describe the preparation and characterization of novel Au( iii ) cyclometallated κ 1 S-azoli(ni)um-2-dithiocarboxylatecomplexes their rearrangement to biscyclometallated 2 -S,S′-azoli(ni)um-2-(methoxy)methanedithiolate complexes.

Language: Английский

Citations

5

Tailoring bisindolyl methane derivatives for dual applications: Substituent-directed probing of cyanide ions and anti-tubercular activity DOI
Rikitha S. Fernandes,

Jyothi Kumari,

Aditi Gangopadhyay

et al.

Journal of Molecular Liquids, Journal Year: 2024, Volume and Issue: 410, P. 125266 - 125266

Published: June 21, 2024

Language: Английский

Citations

5

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature DOI Creative Commons
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary

et al.

Biomedicines, Journal Year: 2022, Volume and Issue: 10(11), P. 2793 - 2793

Published: Nov. 3, 2022

Tuberculosis (TB) is accountable for considerable global morbidity and mortality. Effective TB therapy with multiple drugs completes in about six months. The longer duration of challenges patient compliance contributes to treatment collapse drug resistance (DR) progress. Therefore, new medications an innovative mechanism action are desperately required shorten the therapy's effective control. mycobacterial membrane protein Large 3 (MmpL3) a novel, mycobacteria-conserved recognized promiscuous target used development better treatments multi-drug (MDR-TB) extensively drug-resistant (XDR-TB). This article spotlights MmpL3, clinical studies its inhibitor (SQ109), patent literature. literature on MmpL3 inhibitors was searched PubMed freely available databases (Espacenet, USPTO, PatentScope). SQ109, analog ethambutol (EMB), established has completed Phase 2b-3 trials. Infectex Sequella developing orally active SQ109 partnership treat MDR pulmonary TB. demonstrated activity against drug-sensitive (DS) Mycobacterium tuberculosis (Mtb) synergistic effect isoniazid (INH), rifampicin (RIF), clofazimine (CFZ), bedaquiline (BNQ). combination clofazimine, bedaquiline, pyrazinamide (PZA) been patented due excellent anti-TB MDR-TB, XDR-TB, latent-TB. combinations other (chloroquine, hydroxychloroquine, sutezolid) have also claimed more potent than EMB could substitute intensive stage three- or four-drug combination. Developing promising approach fighting associated DS-TB DR-TB. authors foresee such as future treatment.

Language: Английский

Citations

21

Synthetic approaches, emerging applications, and challenges of indole-based five-membered heterocycles in medicinal chemistry DOI Creative Commons

M. Padmapriya,

Sushruta S. Hakkimane, Santosh L. Gaonkar

et al.

Deleted Journal, Journal Year: 2025, Volume and Issue: 7(3)

Published: March 7, 2025

Abstract Scientists are fascinated by the indole structure due to its diverse biological activities, encompassing both itself and numerous substituted derivatives. Heterocycles, particularly those containing indoles, play pivotal roles in domains of medicinal chemistry, drug designing discovery, agrochemicals, photochemistry, dyes, other applications, which has led their prominence chemistry field. This review highlights applications indole-based five-membered heterocycles as versatile scaffolds for development, emphasizing therapeutic potential antidiabetic, anti-inflammatory, anticancer, antimicrobial, antioxidant agents, antialzheimer anticonvulsant agents. A comprehensive literature search was carried out explore chemical, biological, structural activity correlations hybrids. Studies published between 2017 2024 were chosen from databases such PubMed, Scopus Google Scholar, synthesis, application chemistry. Unique this is exploration structure–activity relationships (SAR), synthetic approaches emerging challenges development drugs. Key insights include innovative strategies enhance efficacy through modifications various derivatives areas. These findings hold great improving design more effective pharmaceuticals. Graphical abstract

Language: Английский

Citations

0

Targeting Mycobacterium Tuberculosis with Azotic-Grafted 3D-Spironchromanone Derivatives: Synthesis, Molecular Docking, and DFT Studies DOI

Fathi Hamed Elghareeb,

E. M. KANDEEL,

M. Abou-Elzahab

et al.

Journal of Molecular Structure, Journal Year: 2025, Volume and Issue: unknown, P. 142267 - 142267

Published: April 1, 2025

Language: Английский

Citations

0